Lineage Cell Therapeutics Inc

NYSE American: LCTX
Share price (4/24/24): $1.10
Market cap (4/24/24): $207 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Samuel George A. III

Samuel George A. III

News Filter

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Announces $14.0 Million Registered Direct Offering

Reports Third Quarter 2023 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC